Rheumatology Advance Access originally published online on April 3, 2008
Rheumatology 2008 47(7):946-951; doi:10.1093/rheumatology/ken118
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEWS |
Autoinflammatory diseases: an update of clinical and genetic aspects
Division of Rheumatology, David Geffen Medical School at UCLA, Los Angeles, CA, USA.
Correspondence to: D. E. Furst, Division of Rheumatology, UCLA, 1000 Veteran Ave., Rehab 39-52, Los Angeles, CA 90095, USA. E-mail: defurst{at}mednet.ucla.edu
| Abstract |
|---|
To review clinical manifestations and genetic features of the autoinflammatory diseases, a group of rare, genetically defined diseases which have been newly grouped into a coherent whole. We performed a literature review using the keywords periodic fever syndrome, autoinflammatory disease and therapy. All relevant original and review articles in English were reviewed. A case report of each autoinflammatory disease was excerpted from the literature and presented. This review summarizes the clinical manifestations, genetic analysis and therapy of FMF, TNF-
receptor-associated periodic fever syndrome, hyperimmunoglobulinaemia D periodic fever syndrome and cryopyrin-associated periodic fever syndrome. These diseases have periodic fever, are hereditary and recurrent, with elevated acute-phase reactants. Differentiating features of these disorders are tabulated. Autoinflammatory diseases have some communalities in their presentation although they represent a relatively diverse group of genetically associated diseases.
KEY WORDS: Autoinflammatory disease, Familial Mediterranean fever, Tumour necrosis factor a receptor associated periodic fever syndrome, Hyperimmunoglobulinemia D periodic fever syndrome, Cryopyrin, Genetic analysis, Amyloidosis, Therapy, TNF
blocker, Interleukin-1 receptor antagonist
Submitted 24 January 2008; Accepted 18 February 2008